Mercè Boada1, Lluís Tárraga2, Isabel Hernández2, Sergi Valero3, Montserrat Alegret2, Agustín Ruiz2, Oscar L Lopez4, James T Becker4. 1. Alzheimer Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain. Electronic address: mboada@Fundacioace.com. 2. Alzheimer Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain. 3. Alzheimer Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain; Servei de Psiquiatria, Hospital Universitari Vall d'Hebron, CIBERSAM, Universitat Autònoma de Barcelona, Barcelona, Spain. 4. Alzheimer's Disease Research Center, University of Pittsburgh, Pittsburgh, PA, USA.
Abstract
OBJECTIVES: Alzheimer's disease (AD) affects people worldwide, and the prevalence is increasing as the population ages. There is an international effort to understand the biology of AD to develop primary and secondary prevention strategies, and to develop effective therapeutic interventions for individuals who are already symptomatic. One of the critically important pieces of all national plans to address AD is the call for the development of service models to deliver quality, effective care based on the best evidence available. METHODS: We describe one type of care model developed by the Fundacio ACE, Institut Catala de Neurociencies Aplicades (Fundacio ACE, Barcelona, Spain) that integrates diagnosis, therapy, follow-up care, daycare, and a day hospital, and does so in the context of an active clinical research and educational program. RESULTS: There were 13,048 individuals newly evaluated and diagnosed in Fundacio ACE between 1996 and 2011. Of these, 6132 had AD (47.0%), 3871 had mild cognitive impairment (MCI) (29.7%), and 1958 had no cognitive impairment (15.0%). Follow-up information is available on 4735 (47.3%) AD and MCI patients, and these data indicate that MCI develops into dementia at a rate of 222.6/1000 person-years. Apolipoprotein E (APOE) genotyping was available in 22.4% of the patients. The ε4 allele occurred in 45.7% of the AD patients, in 37.8% of the MCI subjects, and in 31.6% of those without cognitive impairment. CONCLUSIONS: Fundació ACE can serve as a model system that can be adapted to other settings within their specific cultural, governmental, and legal constraints.
OBJECTIVES:Alzheimer's disease (AD) affects people worldwide, and the prevalence is increasing as the population ages. There is an international effort to understand the biology of AD to develop primary and secondary prevention strategies, and to develop effective therapeutic interventions for individuals who are already symptomatic. One of the critically important pieces of all national plans to address AD is the call for the development of service models to deliver quality, effective care based on the best evidence available. METHODS: We describe one type of care model developed by the Fundacio ACE, Institut Catala de Neurociencies Aplicades (Fundacio ACE, Barcelona, Spain) that integrates diagnosis, therapy, follow-up care, daycare, and a day hospital, and does so in the context of an active clinical research and educational program. RESULTS: There were 13,048 individuals newly evaluated and diagnosed in Fundacio ACE between 1996 and 2011. Of these, 6132 had AD (47.0%), 3871 had mild cognitive impairment (MCI) (29.7%), and 1958 had no cognitive impairment (15.0%). Follow-up information is available on 4735 (47.3%) AD and MCI patients, and these data indicate that MCI develops into dementia at a rate of 222.6/1000 person-years. Apolipoprotein E (APOE) genotyping was available in 22.4% of the patients. The ε4 allele occurred in 45.7% of the ADpatients, in 37.8% of the MCI subjects, and in 31.6% of those without cognitive impairment. CONCLUSIONS: Fundació ACE can serve as a model system that can be adapted to other settings within their specific cultural, governmental, and legal constraints.
Authors: John Q Trojanowski; Steven E Arnold; Jason H Karlawish; Kurt Brunden; Mark Cary; Christos Davatzikos; John Detre; Glen Gaulton; Murray Grossman; Howard Hurtig; Kathryn Jedrziewski; Leo McCluskey; Mary Naylor; Daniel Polsky; Gerard D Schellenberg; Andrew Siderowf; Leslie M Shaw; Vivianna Van Deerlin; Li-San Wang; Rachel Werner; Sharon X Xie; Virginia M-Y Lee Journal: Alzheimers Dement Date: 2010-03 Impact factor: 21.566
Authors: R Ramirez-Lorca; M Boada; M E Saez; I Hernandez; A Mauleon; M Rosende-Roca; P Martinez-Lage; M Gutierrez; L M Real; J Lopez-Arrieta; J Gayan; C Antunez; A Gonzalez-Perez; L Tarraga; A Ruiz Journal: J Nutr Health Aging Date: 2009-03 Impact factor: 4.075
Authors: Jean-Charles Lambert; Kristel Sleegers; Antonio González-Pérez; Martin Ingelsson; Gary W Beecham; Mikko Hiltunen; Onofre Combarros; Maria J Bullido; Nathalie Brouwers; Karolien Bettens; Claudine Berr; Florence Pasquier; Florence Richard; Steven T Dekosky; Didier Hannequin; Jonathan L Haines; Gloria Tognoni; Nathalie Fiévet; Jean-François Dartigues; Christophe Tzourio; Sebastiaan Engelborghs; Beatrice Arosio; Elicer Coto; Peter De Deyn; Maria Del Zompo; Ignacio Mateo; Merce Boada; Carmen Antunez; Jesus Lopez-Arrieta; Jacques Epelbaum; Brit-Maren Michaud Schjeide; Ana Frank-Garcia; Vilmentas Giedraitis; Seppo Helisalmi; Elisa Porcellini; Alberto Pilotto; Paola Forti; Raffaele Ferri; Marc Delepine; Diana Zelenika; Mark Lathrop; Elio Scarpini; Gabriele Siciliano; Vincenzo Solfrizzi; Sandro Sorbi; Gianfranco Spalletta; Giovanni Ravaglia; Fernando Valdivieso; Saila Vepsäläinen; Victoria Alvarez; Paolo Bosco; Michelangelo Mancuso; Francesco Panza; Benedetta Nacmias; Paola Bossù; Olivier Hanon; Paola Piccardi; Giorgio Annoni; David Mann; Philippe Marambaud; Davide Seripa; Daniela Galimberti; Rudolph E Tanzi; Lars Bertram; Corinne Lendon; Lars Lannfelt; Federico Licastro; Dominique Campion; Margaret A Pericak-Vance; Hilkka Soininen; Christine Van Broeckhoven; Annick Alpérovitch; Agustin Ruiz; M Ilyas Kamboh; Philippe Amouyel Journal: J Alzheimers Dis Date: 2010 Impact factor: 4.472
Authors: J M Burns; B B Cronk; H S Anderson; J E Donnelly; G P Thomas; A Harsha; W M Brooks; R H Swerdlow Journal: Neurology Date: 2008-07-15 Impact factor: 9.910
Authors: Carmen Antúnez; Mercè Boada; Antonio González-Pérez; Javier Gayán; Reposo Ramírez-Lorca; Juan Marín; Isabel Hernández; Concha Moreno-Rey; Francisco Jesús Morón; Jesús López-Arrieta; Ana Mauleón; Maitée Rosende-Roca; Fuensanta Noguera-Perea; Agustina Legaz-García; Laura Vivancos-Moreau; Juan Velasco; José Miguel Carrasco; Montserrat Alegret; Martirio Antequera-Torres; Salvadora Manzanares; Alejandro Romo; Irene Blanca; Susana Ruiz; Anna Espinosa; Sandra Castaño; Blanca García; Begoña Martínez-Herrada; Georgina Vinyes; Asunción Lafuente; James T Becker; José Jorge Galán; Manuel Serrano-Ríos; Enrique Vázquez; Lluís Tárraga; María Eugenia Sáez; Oscar L López; Luis Miguel Real; Agustín Ruiz Journal: Genome Med Date: 2011-05-31 Impact factor: 11.117
Authors: Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois Journal: Mov Disord Date: 2007-09-15 Impact factor: 10.338
Authors: Scott C Neu; Judy Pa; Walter Kukull; Duane Beekly; Amanda Kuzma; Prabhakaran Gangadharan; Li-San Wang; Klaus Romero; Stephen P Arneric; Alberto Redolfi; Daniele Orlandi; Giovanni B Frisoni; Rhoda Au; Sherral Devine; Sanford Auerbach; Ana Espinosa; Mercè Boada; Agustín Ruiz; Sterling C Johnson; Rebecca Koscik; Jiun-Jie Wang; Wen-Chuin Hsu; Yao-Liang Chen; Arthur W Toga Journal: JAMA Neurol Date: 2017-10-01 Impact factor: 18.302
Authors: Ana Espinosa; Montserrat Alegret; Pedro Pesini; Sergi Valero; Asunción Lafuente; Mar Buendía; Itziar San José; Marta Ibarria; Miguel A Tejero; Joan Giménez; Susana Ruiz; Isabel Hernández; Francesc Pujadas; Pablo Martínez-Lage; Josep Munuera; Javier Arbizu; Lluis Tárraga; Suzanne B Hendrix; Agustín Ruiz; James T Becker; Susan M Landau; Oscar Sotolongo-Grau; Manuel Sarasa; Mercè Boada Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472